Cigna shares fell 1.3% after earnings, a roughly flat reaction. The company raised its 2026 EPS outlook, while Evernorth’s earnings were described as in line with expectations; the excerpt does not establish a specific source of investor disappointment.
Shares of Cigna Group declined 3.2% post-earnings, as investor disappointment centered on the company's cautious full-year 2026 outlook despite management highlighting raised adjusted EPS guidance. The market response suggests concerns about decelerating growth, possibly tied to margin pressures or uncertainty in addressing rising healthcare costs.
Cigna Group demonstrated resilient performance in the third quarter of 2025, delivering strong revenue growth of $69.7 billion and adjusted earnings per share of $7.83 while strategically investing in innovation and expanding market access.